m+Medelevator.RU
← Поиск публикаций
Cureus · 2026

Genetically Confirmed Localized Perianal Hailey-Hailey Disease Successfully Treated With Topical Difamilast: A Case Report.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Maekawa Maho, Yoshida Kenji, Tanese Keiji, Ohara Fumiko, Ishiko Akira

Аннотация

Hailey-Hailey disease, also known as familial benign chronic pemphigus, is a rare autosomal dominant acantholytic dermatosis caused by abnormalities in ATP2C1. The disease typically affects intertriginous areas such as the axillae and groin, whereas localized involvement limited to the perianal region is exceptionally rare. We report the case of a 48-year-old woman who presented with pruritus and pain in the perianal region for one year. The lesion had been refractory to topical corticosteroid therapy. Physical examination revealed a brownish, thickened plaque with erosion and maceration around the anus. Histopathological examination demonstrated suprabasal clefting and acantholysis, creating a dilapidated brick wall appearance. Direct immunofluorescence staining was negative. Genetic analysis identified a donor splice-site mutation in ATP2C1 (c.899+1G>T), confirming the diagnosis of Hailey-Hailey disease. Treatment with topical difamilast, a phosphodiesterase-4 inhibitor, led to improvement of pruritus and gradual epithelialization of the erosion over two months, with no recurrence during seven months of follow-up. Localized perianal Hailey-Hailey disease is an important diagnostic consideration in chronic treatment-resistant perianal erosions. This case highlights the value of careful clinicopathological evaluation and genetic testing in atypical presentations and suggests that topical difamilast may be a useful therapeutic option for localized disease.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты